首页|帕瑞昔布钠超前镇痛联合术后舒芬太尼静脉自控镇痛在下肢骨折手术患者中的应用效果

帕瑞昔布钠超前镇痛联合术后舒芬太尼静脉自控镇痛在下肢骨折手术患者中的应用效果

扫码查看
目的:观察帕瑞昔布钠超前镇痛联合术后舒芬太尼静脉自控镇痛在下肢骨折手术患者中的应用效果.方法:回顾性分析2022 年 7 月至 2023 年 5 月该院收治的 60 例下肢骨折手术患者的临床资料,按不同镇痛方案将其分为对照组与观察组各 30 例.两组均进行全身麻醉,在此基础上,对照组术后予以枸橼酸舒芬太尼注射液静脉自控镇痛,观察组在对照组基础上联合帕瑞昔布钠超前镇痛.比较两组麻醉相关指标(麻醉苏醒时间、拔管时间、意识恢复时间),术后疼痛程度[视觉模拟评分法(VAS)]评分、苏醒期躁动[Riker镇静和躁动(SAS)]评分、手术前后应激指标[皮质醇(Cor)、去甲肾上腺素(NE)]水平和不良反应发生率.结果:两组麻醉苏醒时间、拔管时间、意识恢复时间比较,差异均无统计学意义(P>0.05);术后 6、12、24、48 h,观察组VAS评分均低于对照组,差异有统计学意义(P<0.05);观察组苏醒期SAS评分低于对照组,差异有统计学意义(P<0.05);术后 24 h,两组Cor、NE水平均高于治疗前,但观察组低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:帕瑞昔布钠超前镇痛联合术后舒芬太尼静脉自控镇痛应用于下肢骨折手术患者可降低苏醒期SAS评分和应激指标水平,其效果优于单纯术后舒芬太尼静脉自控镇痛.
Application effects of Parecoxib sodium preemptive analgesia combined with postoperative Sufentanil patient-controlled intravenous analgesia in patients undergoing lower limb fracture surgeries
Objective:To observe application effects of Parecoxib sodium preemptive analgesia combined with postoperative Sufentanil patient-controlled intravenous analgesia in patients undergoing lower limb fracture surgeries.Methods:The clinical data of 60 patients with lower limb fracture surgeries admitted to this hospital from July 2022 to May 2023 were retrospectively analyzed.According to different analgesic schemes,they were divided into control group and observation group,30 cases in each group.Both groups underwent general anesthesia.On this basis,The control group was given Sufentanil citrate injection for patient-controlled intravenous analgesia after the surgery,while the observation group was combined with Parecoxib sodium for preemptive analgesia on the basis of that of the control group.The levels of anesthesia related indicators(anesthesia recovery time,extubation time,consciousness recovery time),the postoperative pain degree[visual analogue scale(VAS)]score,the emergence agitation[Riker sedation and agitation(SAS)]score,the stress indexes[cortisol(Cor),norepinephrine(NE)]levels before and after the surgery,and the incidence of adverse reactions were compared between the two groups.Results:There were no significant differences in the anesthesia recovery time,the extubation time and the consciousness recovery time between the two groups(P>0.05).6,12,24 and 48 h after the surgery,the VAS scores of the observation group were lower than those of the control group,and the differences were statistically significant(P<0.05).The SAS score of the observation group in the recovery period was lower than that of the control group,and the difference was statistically significant(P<0.05).24 h after the surgery,the levels of Cor and NE in the two groups were higher than those before the treatment,but those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Parecoxib sodium preemptive analgesia combined with postoperative Sufentanil patient-controlled intravenous analgesia in the patients undergoing lower limb fracture surgeries can reduce the SAS scores and the stress index levels during the recovery period.Moreover,it is superior to simple postoperative Sufentanil patient-controlled intravenous analgesia.

Parecoxib sodiumPreemptive analgesiaSufentanilPatient-controlled intravenous analgesiaLower limb fracture surgeryStress response

何迎春

展开 >

商丘市第三人民医院麻醉科,河南 商丘 476000

帕瑞昔布钠 超前镇痛 舒芬太尼 静脉自控镇痛 下肢骨折手术 应激反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(15)
  • 10